{
  "resourceType" : "RegulatedAuthorization",
  "id" : "authherceptin150",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: RegulatedAuthorization authherceptin150</b></p><a name=\"authherceptin150\"> </a><a name=\"hcauthherceptin150\"> </a><p><b>identifier</b>: <code>https://pmda-approvalandlicenseno/</code>/21300AMY00128\u00a0(use:\u00a0official,\u00a0)</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-medprodherceptin150.html\">MedicinalProductDefinition: identifier = http://iyaku.info/medicine#4291447D2024; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription</a></p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi/ /#100000072062}\">Marketing Authorisation</span></p><p><b>region</b>: <span title=\"Codes:{urn:iso:std:iso:3166 JP}\">Japan</span></p><p><b>status</b>: <span title=\"Codes:{http://hl7.org/fhir/publication-status active}\">Active</span></p><p><b>statusDate</b>: 2002-08-01 13:28:17+0000</p><p><b>holder</b>: <a href=\"Organization-orgchugai.html\">Organization Chugai Pharmaceutical Co., Ltd.</a></p></div>"
  },
  "identifier" : [{
    "use" : "official",
    "system" : "https://pmda-approvalandlicenseno/",
    "value" : "21300AMY00128"
  }],
  "subject" : [{
    "reference" : "MedicinalProductDefinition/medprodherceptin150"
  }],
  "type" : {
    "coding" : [{
      "system" : "https://spor.ema.europa.eu/rmswi/",
      "code" : "/#100000072062"
    }],
    "text" : "Marketing Authorisation"
  },
  "region" : [{
    "coding" : [{
      "system" : "urn:iso:std:iso:3166",
      "code" : "JP"
    }],
    "text" : "Japan"
  }],
  "status" : {
    "coding" : [{
      "system" : "http://hl7.org/fhir/publication-status",
      "code" : "active"
    }],
    "text" : "Active"
  },
  "statusDate" : "2002-08-01T13:28:17Z",
  "holder" : {
    "reference" : "Organization/orgchugai"
  }
}